High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide

Investigative Radiology

Volumn 44, Issue 7, 2009, Pages 375-383

  Christoforidis, Gregory A ^b   Yang, Ming ^a   Kontzialis, Marinos S ^a   Larson, Douglas G ^a   Abduljalil, Amir ^a   Basso, Michelle ^a   Yang, Weilian ^a   Ray Chaudhury, Abhik ^a   Heverhagen, Johannes ^a   Knopp, Michael V ^a   Barth, Rolf F ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

8T MRI; Hypoxia; Microvascularity; SHU 555C; Tumor; USPIO

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLIOMA; HISTOPATHOLOGY; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL RESOLUTION; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; TUMOR VASCULARIZATION;

EID: 67651022025     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181a8afea     Document Type: Article

References (70)

1. Burgess RE, Yu Y, Christoforidis GA, et al. Human leptomeningeal and cortical vascular anatomy of the cerebral cortex at 8 Tesla. J Comput Assist Tomogr. 1999;23:850-856.
2. Dashner RA, Kangarlu A, Clark DL, et al. Limits of 8-Tesla magnetic resonance imaging spatial resolution of the deoxygenated cerebral microvas- culature. J Magn Reson Imaging. 2004;19:303-307.
3. Christoforidis GA, Bourekas EC, Baujan M, et al. High resolution MRI of the deep Brain vascular anatomy at 8 Tesla: susceptibility-based enhancement of the venous structures. J Comput Assist Tomogr. 1999;23:857-866.
4. Dashner RA, Chakeres DW, Kangarlu A, et al. MR Imaging visualization of the cerebral microvasculature: a comparison of live and postmortem studies at 8T. AJNR. 2003;24:1881-1884.
5. Christoforidis GA, Kangarlu A, Abduljalil AM, et al. Susceptibility-based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. AJNR. 2004;25:756-760.
6. Christoforidis GA, Grecula JC, Newton HB, et al. Visualization of micro- vascularity in glioblastoma multiforme with 8-T high-spatial-resolution MR imaging. AJNR. 2002;23:1553-1556.
7. Abduljalil AM, Robitaille PM. Macroscopic susceptibility in ultra high field MRI. JComput Assist Tomogr. 1999;23:832-841.
8. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superparamagnetic iron oxide: characterization ofa new class ofcontrast agents for MR imaging. Radiology. 1990;175:489-493.
9. Yang M, Christoforidis GA, Figueredo T, et al. Dosage determination of ultrasmall particles ofironoxide for the delineationofmicrovasculature in the Wistar rat brain. Invest Radiol. 2005;40:655-660.
10. Tombach B, Reimer P, Bremer C, et al. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study. NMR Biomed. 2004;17:500-506.
11. Clarke SE, Weinmann HJ, Dai E, et al. Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits. Radiology. 2000;214:787-794.
12. Kobayashi N, Allen N, Clendenon NR, et al. An improved rat brain-tumor model. J Neurosurg. 1980;53:808 -815.
13. Koestner A, Swenberg JA, Wechsler W. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am J Pathol. 1971;63:37-56.
14. Ko L, Koestner K, Wechsler W. Morphological characterization of nitro- sourea-induced glioma cell lines and clones. Acta Neuropathol (Berl). 1980; 51:23-31.
15. Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2, and CNS-1 gliomas. J Neurooncol.2009 Apr 21. [Epub ahead of print].
16. Lord EM, Harwell L, Koch CJ. Detection of hypoxic cells by monoclonal antibodyrecognizing 2-nitroimidazole adducts. Cancer Res. 1993;53:5721-5726.
17. Evans SM, Joiner B, Jenkins WT, et al. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol- 1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. Br J Cancer. 1995;72: 875-882.
18. Koch CJ, Lord EM, Shapiro IM, et al. Imaging hypoxia and blood flow in normal tissues. Adv Exp Med Biol. 1997;428:585-593.
19. Koch CJ, Evans SM, Lord EM. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acet- amide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity. Br J Cancer. 1995;72:869-874.
20. Dennie J, Mandeville JB, Boxerman JL, et al. NMR imaging of changes in vascular morphology because of tumor angiogensis. Magn Reson Med. 1998;40:793-799.
21. Frericks BB, Wacker F, Loddenkemper C, et al. Magnetic resonance imaging of experimental inflammatory bowel disease: quantitative and qualitative analyses with histopathologic correlation in a rat model using the ultrasmall iron oxide SHU 555 C. Invest Radiol. 2009;44:23-30.
22. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison ofmagnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724.
23. Persigehl T, Matuszewski L, Kessler T, et al. Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging. Invest Radiol. 2007;42:791-796.
24. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Meth Med Res. 1999;8:135-160.
25. Neeman M, Provenzale JM, Dewhirst MW. Magnetic resonance imaging applications in the evaluation of tumor angiogenesis. Semin Radiat Oncol. 2001;11:70-82.
26. Krishna MC, Subramanian S, Kuppusamy P, et al. Magnetic resonance imaging for in vivo assessment of tissue oxygen concentration. Semin Radiat Oncol. 2001;11:58 -69.
27. Evans SM, Jenkins WT, Joiner B, et al. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s. c. tumors. Cancer Res. 1996;56:405-411.
28. Jensen RL. Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg Focus. 2006;20:E24.
29. Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 1988;14:831-838.
30. Rice GC, Hoy C, Schimke RT. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad SciUSA. 1986;83:5978-5982.
31. Sanna K, Rofstad EK. Hypoxia-induced resistance to doxorubicin and meth- otrexate in human melanoma cell lines in vitro. Int J Cancer. 1994;58:258 - 262.
32. Wilson RE, Keng PE, Sutherland RM. Drug resistance in chinese hamster ovary cells during recovery from severe hypoxia. J Natl Cancer Inst. 1989;81:1235-1240.
33. Brizel DM, Sibley GS, Prosnitz LR, et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;38:285-289.
34. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol. 1998;48:149-156.
35. Unruh A, Ressel A, Mohamed HG, et al. The hypoxia-inducible factor-1a is a negative factor for tumor therapy. Oncogene. 2003;22:3213-3220.
36. Costouros NG, Diehn FE, Libutti SK. Molecular imaging of tumor angio- genesis. J Cell Biochem Suppl. 2002;39:72-78.
37. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249 -257.
38. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lan- thanide chelates in normal brain: contrast because of magnetic susceptibility effects. Magn Reson Med. 1988;6:164-174.
39. Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist. 2004;9:528 -537.
40. Pauliah M, Saxena V, Haris M, et al. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma. Magn Reson Imaging. 2007;25:1292-1299.
41. Slotboom J, Schaer R, Ozdoba C, et al. A novel method for analyzing DSCE- images with an application to tumor grading. Invest Radiol. 2008;43:843-853.
42. Ogawa S, Lee TM, Kay AR, et al. Brain magnetic resonance imaging with contrast dependent blood level oxygenation. Proc Natl Acad Sci (USA). 1990;87:9868 -9872.
43. Ogawa S, Lee TM. Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med. 1990;16:9 -18.
44. Kennan RP, Zhong J, Gore JC. Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med. 1994;31:9-21.
45. Punwani S, Ordidge RJ, Cooper CE, et al. MRI measurements of cerebral deoxyhaemoglobin concentration [dHb] - correlation with near infrared spec- troscopy (NIRS). NMR Biomed. 1998;11:281-289.
46. Dousset V, Gomez C, Petry KG, et al. Dose and scanning delay using USPIO for central nervous system macrophage imaging. MAGMA. 1999;8:185-189.
47. Taupitz M, Schnorr J, Abramjuk C, et al. New generation of monomerstabi- lized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits. J Magn Reson Imaging. 2000;12:905-911.
48. Laghi A, Paolantonio P, Panebianco V, et al. Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms. Invest Radiol. 2004;39:666-670.
49. Taschner CA, Wetzel SG, Tolnay M, et al. Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. AJR. 2005;185: 1477-1486.
50. Tamura H, Hatazawa J, Toyoshima H, et al. Detection of deoxygenation- related signal change in acute ischemic stroke patients by t2z.ast;-weighted magnetic resonance imaging. Stroke. 2002;33:967-971.
51. Hermier M, Nighoghossian N. Contribution of susceptibility-weighted imaging to acute stroke assessment. Stroke. 2004;35:1989-1994.
52. Yetkin FZ, Mendelsohn D. Hypoxia imaging in brain tumors. Neuroimaging Clin NAm. 2002;12:537-552.
53. Baudelet C, Ansiaux R, Jordan BF, et al. Physiological noise in murine solid tumours using T2z.ast;-weighted gradient-echo imaging: a marker of tumour acute hypoxia? Phys Med Biol. 2004;49:3389-3411.
54. Thomas DL, Lythgoe MF, Gadian DG, et al. Rapid simultaneous mapping of T2 and T2z.ast; by multiple acquisition of spin and gradient echoes using interleaved echo planar imaging (MASAGE-IEPI). Neuroimage. 2002;15:992-1002.
55. Lin W, Paczynski RP, Celik A, et al. Experimental hypoxemic hypoxia: effects of variation in hematocrit on magnetic resonance T2z.ast;-weighted brain images. J Cereb Blood Flow Metab. 1998;18:1018-1021.
56. Packard SD, Mandeville JB, Ichikawa T, et al. Functional response oftumor vasculature to PaCO2: determination oftotal and microvascular blood volume by MRI. Neoplasia. 2003;5:330-338.
57. Nwaigwe CI, Roche MA, Grinberg O, et al. Effect of hyperventilation on brain tissue oxygenation and cerebrovenous PO2 in rats. Brain Res. 2000;868:150-156.
58. Robinson SP, Collingridge DR, Howe FA, et al. Tumour response to hyper- capnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed. 1999;12:98 -106.
59. Maseide K, Rofstad EK. Intratumour heterogeneity in microvessel oxyhae- moglobin saturations. Cancer Lett. 2001;162:245-251.
60. Seitz RJ, Deckert M, Wechsler W. Vascularization of syngenic intracerebral RG2 and F98 rat transplantation tumors: a histochemical and morphometric study by use of ricinus communis agglutinin I. Acta Neuropathol (Berl), 1988;76:599-605.
61. Kaur B, Barth RF. Rat glioma models for preclinical evaluation of novel therapeutic and diagnostic modalities. In: Van Meir EG, ed. CNS Cancer, Models, Prognostic Factors and Targets. New York, NY: Springer Publishing; 2009.
62. Mathieu D, Lecomte R, Tsanaclis AM, et al. Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model. Can J Neurol Sci. 2007;347:296-306.
63. Zhang J, van Zijl PCM, Laterra J, et al. Unique patterns of diffusion directionality in rat brain tumors revealed by high-resolution diffusion tensor MRI. Magn Reson Med. 2007;58:454-462.
64. Blanchard J, Mathieu D, Patenaude Y, et al. MR-pathological comparison in F98-Fischer glioma model using a human gantry. Can J Neurol Sci. 2006;33:86-91.
65. Valable S, Lemasson B, Farion R, et al. Assessment of blood volume, vessel size, and the expression of angiogenic factors in tow rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed. 2008;21:1043-1056.
66. Ferrier MC, Sarin H, Fung SH, et al. Validation of dynamic contrastenhanced magnetic resonance imagingderived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. Neoplasia. 2007;9: 546-555.
67. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology. 2002;224:797-803.
68. Weltens C, Menten J, Feron M, et al. Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother Oncol. 2001;60:49-59.
69. Vos Mj, Uitdehaag BMJ, Barkhof F, et al. Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology. 003;60:826-830.
70. Mori N, Miki Y, Kasahara S, et al. Susceptibility-weighted imaging at 3 tesla delineates the optic radiation. Invest Radiol. 2009;44:140-145.